Format

Send to

Choose Destination
Semin Oncol. 2017 Apr;44(2):159-160. doi: 10.1053/j.seminoncol.2017.06.001. Epub 2017 Jul 4.

Prevention of 5-fluorouracil-induced early severe toxicity by pre-therapeutic dihydropyrimidine dehydrogenase deficiency screening: The multiparametric approach is not convincing.

Author information

1
Oncopharmacology laboratory, Centre Antoine Lacassagne, Nice, France. Electronic address: marie-christine.etienne@nice.unicancer.fr.
2
Biochemistry laboratory, CHU Tours-Bretonneau, Tours, France.
3
Biochemistry laboratory, CHU Nîmes-Carémeau, Nîmes, France.
4
Laboratoire de Biologie Médicale Oncologique, Institut Claudius-Regaud, CRCT, Toulouse, France.
5
Biochemistry Department, Hopital Européen Georges Pompidou, Paris, France.
6
Department of Clinical Pharmacy, SIPAM, Institut de Cancérologie Gustave Roussy, Villejuif, France.
7
Department of Clinical Pharmacology, CHU Jean Minjoz, Besançon, France.
8
SMARTc, Department of Pharmacokinetics, CHU Timone, Marseille, France.

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center